Topics
Novo Nordisk
Every story about Novo Nordisk, updated as news breaks.
What to know
- FDA added new warnings to Ozempic, Zepbound, Wegovy and Mounjaro for NAION risk. Nov 9
- Patients should watch for sudden vision loss or blurred vision and report changes immediately. Nov 9
- Retatrutide reduced A1C 2.2% after 80 weeks, higher than Ozempic’s 1.8%. Oct 28
- Highest dose of retatrutide led to 44‑47 lb weight loss, about double Ozempic’s effect. Oct 28
- Amazon’s program bundles primary care, pharmacy and virtual care to simplify obesity treatment. Apr 21
Timeline
- Nov 9, 2026
- Oct 28, 2026
- Apr 21, 2026
- Dec 22, 2025



